Why the study?
Does intravenous procaine or procaine amide reduce ectopic ventricular tachycardia in dogs with acute myocardial infarction?
Does intravenous procaine or procaine amide reduce ectopic ventricular tachycardia in dogs with acute myocardial infarction?
In a canine model of acute myocardial infarction, intravenous procaine amide effectively suppresses ectopic ventricular tachycardia, whereas procaine is ineffective.
May guide antiarrhythmic testing in ischemic models; leaves open human translation for ventricular tachycardia.
In tests using dogs with ectopic ventricular tachycardia resulting from myocardial infarction, procaine has been found to be without practical value as an ectopic impulse suppressor agent. Procaine amide has proved to be very effective in reducing the ectopic rate of high frequency tachycardias to low levels, thus eliminating danger of death from the tachycardia. Procaine amide usually does not produce an entirely normal rhythm but this is of little practical importance. The toxicity of procaine amide is relatively low. For approximately equivalent results, in the tachycardias studied, the dosage of procaine amide must be two to three times that of quinidine.
No takes yet. Share an insight, caveat, or question.
Harris et al. (1952) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: